Kymera Therapeutics KYMR Institutional Ownership

NASDAQ KYMR

$110.12 -1.67 (-1.49%)

At close: Oct 1, 2026 · 4:00 PM EDT

Institutions by Trading Activity

279 Institutions

Increased 145 52.0%

Unchanged 49 17.6%

Reduced 85 30.5%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

99.29%

▲+0.56 pp QoQ

Shares Held by Institutions

97.48Mn

of 98.18Mn outstanding

▲+2.13% QoQ

Shares Outstanding

98.18Mn

700.45K held outside 13F filers

Institutional Investors

279

filed 13F for Jun 2026

▲+24 vs prior quarter

Net Shares Added (QoQ)

+2.03Mn

accumulated since last quarter

Value of Holdings

$10.90Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Kymera Therapeutics, Inc. (NASDAQ:KYMR) showed up in the 13F filings of 279 institutional investors as of June 2026.

Their combined ownership stood at 99.3% of outstanding shares in June 2026, up from 98.7% in March 2026.
They increased total shares held in Kymera Therapeutics by 2.13% from last quarter, and the number of investors in KYMR increased 34.13% annually.
Among the 279 funds, 145 bought more Kymera Therapeutics shares, 85 sold down, and 49 held their ground.
Altogether, these fund groups held 97.48Mn shares in KYMR by June 2026, up by 2.03Mn shares quarter on quarter, and up 19.43Mn shares year over year.
As of June 30, 2026, the biggest holder of Kymera Therapeutics is FMR LLC at 12.35Mn shares, representing 12.58% of shares outstanding.
The most significant purchases of KYMR for the quarter ending June 2026 came from PRICE T ROWE ASSOCIATES INC /MD/ (1.05Mn), T. Rowe Price Investment Management, Inc. (792.26K), NORGES BANK (757.25K), FMR LLC (649.31K), Sixth Street Partners Management Company, L.P. (529.73K).
The biggest sellers of Kymera Therapeutics for the quarter ending June 2026 included Atlas Venture Life Science Advisors, LLC (1.73Mn), BVF INC/IL (1.63Mn), Commodore Capital LP (500.0K), Capital Research Global Investors (284.39K), Siren, L.L.C. (251.0K).
Kymera Therapeutics's 10 largest shareholders as of June 2026 include FMR LLC (12.35Mn), BAKER BROS. ADVISORS LP (8.66Mn), Avoro Capital Advisors LLC (7.47Mn), PRICE T ROWE ASSOCIATES INC /MD/ (7.11Mn), T. Rowe Price Investment Management, Inc. (6.26Mn), BlackRock, Inc. (5.54Mn), BVF INC/IL (3.87Mn), WELLINGTON MANAGEMENT GROUP LLP (3.68Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.99Mn), Siren, L.L.C. (2.94Mn) per Business Quant data.

Form 13F Holdings

279 Institutional Holders

Report period 30 Jun, 2026

Total shares held 97.48Mn

Of outstanding 99.29%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	FMR LLC	0000315066	12,349,256	12.58%	▲649,306	+5.55%	$1.42Bn
2	BAKER BROS. ADVISORS LP	0001263508	8,657,242	8.82%	0	0.00%	$992.73Mn
3	Avoro Capital Advisors LLC	0001633313	7,474,747	7.61%	0	0.00%	$857.13Mn
4	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	7,112,980	7.25%	▲1,052,133	+17.36%	$815.65K
5	T. Rowe Price Investment Management, Inc.	0001897612	6,257,261	6.37%	▲792,264	+14.50%	$717.52K
6	BlackRock, Inc.	0002012383	5,538,210	5.64%	▲477,334	+9.43%	$635.07Mn
7	BVF INC/IL	0001056807	3,872,052	3.94%	▼1,630,658	-29.63%	$444.01Mn
8	WELLINGTON MANAGEMENT GROUP LLP	0000902219	3,675,028	3.74%	▼214,659	-5.52%	$421.42Mn
9	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	2,992,193	3.05%	▲118,137	+4.11%	$343.11Mn
10	Siren, L.L.C.	0002005245	2,935,830	2.99%	▼251,000	-7.88%	$336.65Mn
11	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	2,932,378	2.99%	▲52,054	+1.81%	$336.26Mn
12	Atlas Venture Life Science Advisors, LLC	0001917529	2,847,541	2.90%	▼1,730,467	-37.80%	$326.53Mn
13	State Street Corp	0000093751	2,737,226	2.79%	▲347,459	+14.54%	$313.88Mn
14	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,816,331	1.85%	▲170,981	+10.39%	$208.32Mn
15	Capital Research Global Investors	0001422848	1,388,881	1.41%	▼284,394	-17.00%	$159.26Mn
16	Goldman Sachs Group Inc	0000886982	1,187,333	1.21%	▲298,924	+33.65%	$136.15Mn
17	UBS Group AG	0001610520	1,007,777	1.03%	▼16,075	-1.57%	$115.56Mn
18	ALLIANCEBERNSTEIN L.P.	0001109448	981,521	1.00%	▲93,486	+10.53%	$81.75Mn
19	DRIEHAUS CAPITAL MANAGEMENT LLC	0000938206	919,233	0.94%	▼124,350	-11.92%	$105.41Mn
20	Merck & Co., Inc.	0000310158	772,165	0.79%	0	0.00%	$88.54Mn

Showing 1 to 20 of 279 holders